Helena Slaets

703 total citations
17 papers, 482 citations indexed

About

Helena Slaets is a scholar working on Immunology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Helena Slaets has authored 17 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Helena Slaets's work include Cytokine Signaling Pathways and Interactions (9 papers), Multiple Sclerosis Research Studies (5 papers) and Reproductive System and Pregnancy (4 papers). Helena Slaets is often cited by papers focused on Cytokine Signaling Pathways and Interactions (9 papers), Multiple Sclerosis Research Studies (5 papers) and Reproductive System and Pregnancy (4 papers). Helena Slaets collaborates with scholars based in Belgium, Netherlands and Australia. Helena Slaets's co-authors include Niels Hellings, Piet Stinissen, Jerome J. A. Hendriks, Kris Janssens, Chris Van den Haute, Veerle Baekelandt, Helga E. de Vries, C Dijkstra, Jack van Horssen and Sven Hendrix and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of the New York Academy of Sciences and Molecular Therapy.

In The Last Decade

Helena Slaets

17 papers receiving 476 citations

Peers

Helena Slaets

IMMUN

NEURO

ONCOL

PFM

Eleonora Piras Italy

Xiaobo Sun China

Kazushiro Takata Japan

Martin Herold Germany

Kang Guo China

Ying Esbensen Norway

Xiao-Hong Lin China

Barbara Gisevius Germany

Jaekyung C. Song United States

Toru Koda Japan

Eleonora Piras Italy

Helena Slaets

105 ×0.6

IMMUN

277 ×2.0

104 ×0.8

NEURO

126 ×1.1

ONCOL

183 ×2.5

PFM

Citations per year, relative to Helena Slaets Helena Slaets (= 1×) peers Eleonora Piras

Countries citing papers authored by Helena Slaets

Since Specialization

Citations

This map shows the geographic impact of Helena Slaets's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Slaets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Slaets more than expected).

Fields of papers citing papers by Helena Slaets

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Slaets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Slaets. The network helps show where Helena Slaets may publish in the future.

Co-authorship network of co-authors of Helena Slaets

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Slaets. A scholar is included among the top collaborators of Helena Slaets based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Slaets. Helena Slaets is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Slaets, Helena, et al.. (2024). Are immunosenescent T cells really senescent?. Aging Cell. 23(10). e14300–e14300. 15 indexed citations

Slaets, Helena, et al.. (2024). Navigating oligodendrocyte precursor cell aging in brain health. Mechanisms of Ageing and Development. 220. 111959–111959. 9 indexed citations

Slaets, Helena, et al.. (2023). Train your T cells: How skeletal muscles and T cells keep each other fit during aging. Brain Behavior and Immunity. 110. 237–244. 6 indexed citations

Wauters, Lucas, Helena Slaets, Kim De Paepe, et al.. (2021). Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial. The Lancet. Gastroenterology & hepatology. 6(10). 784–792. 58 indexed citations

Janssens, Kris, Jennifer Vandooren, Chris Van den Haute, et al.. (2020). Oncostatin M-induced astrocytic tissue inhibitor of metalloproteinases-1 drives remyelination. Proceedings of the National Academy of Sciences. 117(9). 5028–5038. 28 indexed citations

Broux, Bieke, et al.. (2016). Tolerogenic Dendritic Cells Generated by in Vitro Treatment with SAHA are not Stable in Vivo. Cell Transplantation. 25(6). 1207–1218. 4 indexed citations

Janssens, Kris, Anurag Maheshwari, Chris Van den Haute, et al.. (2015). Oncostatin M protects against demyelination by inducing a protective microglial phenotype. Glia. 63(10). 1729–1737. 24 indexed citations

Janssens, Kris, Helena Slaets, & Niels Hellings. (2015). Immunomodulatory properties of the IL‐6 cytokine family in multiple sclerosis. Annals of the New York Academy of Sciences. 1351(1). 52–60. 40 indexed citations

Janssens, Kris, Chris Van den Haute, Veerle Baekelandt, et al.. (2014). Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis. Brain Behavior and Immunity. 45. 180–188. 49 indexed citations

10.

Slaets, Helena, Sofie Nelissen, Kris Janssens, et al.. (2014). Oncostatin M Reduces Lesion Size and Promotes Functional Recovery and Neurite Outgrowth After Spinal Cord Injury. Molecular Neurobiology. 50(3). 1142–1151. 32 indexed citations

11.

Janssens, Kris, Chris Van den Haute, Veerle Baekelandt, et al.. (2014). Leukemia inhibitory factor shifts the immune balance towards regulatory T cells. Journal of Neuroimmunology. 275(1-2). 155–155. 4 indexed citations

12.

Maheshwari, Anurag, Kris Janssens, Jeroen F. J. Bogie, et al.. (2013). Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination. Mediators of Inflammation. 2013. 1–11. 32 indexed citations

13.

Hendriks, Jerome J. A., et al.. (2012). Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses. Journal of Neuroimmunology. 255(1-2). 45–53. 28 indexed citations

14.

Slaets, Helena, Jerome J. A. Hendriks, Piet Stinissen, Trevor J. Kilpatrick, & Niels Hellings. (2010). Therapeutic potential of LIF in multiple sclerosis. Trends in Molecular Medicine. 16(11). 493–500. 27 indexed citations

15.

Slaets, Helena, Jerome J. A. Hendriks, Chris Van den Haute, et al.. (2010). CNS-targeted LIF Expression Improves Therapeutic Efficacy and Limits Autoimmune-mediated Demyelination in a Model of Multiple Sclerosis. Molecular Therapy. 18(4). 684–691. 24 indexed citations

16.

Hendriks, Jerome J. A., Helena Slaets, Helga E. de Vries, et al.. (2008). Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. Journal of Neuroimmunology. 204(1-2). 52–57. 55 indexed citations

17.

Slaets, Helena, Debora Dumont, Joris Vanderlocht, et al.. (2008). Leukemia inhibitory factor induces an antiapoptotic response in oligodendrocytes through Akt‐phosphorylation and up‐regulation of 14‐3‐3. PROTEOMICS. 8(6). 1237–1247. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact